Excerpta Medica BV - Adelphi Group

Excerpta Medica is a full-service, global medical communications agency with decades of experience partnering with the healthcare industry. With offices in Amsterdam, London, and Philadelphia, and an extensive network through Omnicom and Adelphi, we can develop innovative programmes that span key markets and beyond. Our services include strategic consultancy, publication planning, medical education, digital engagement, and custom publishing. We develop and implement innovative marketing communication solutions across all media with a commitment to quality that ensures smooth and timely execution. **All our programmes are based on our core competencies** Strategic consultancy is the cornerstone. Our strategic consultants have expertise in all aspects of medical communications and all stages of the product lifecycle, such as blockbuster drug launches, niche market communications, and lifecycle management. **Depth of scientific and medical knowledge** We have extensive experience across fast-growing key therapeutic areas including oncology, diabetes, cardiology, and thrombosis. With our strong in-house medical team, we are able to develop expertise quickly in any area. **Thorough understanding of the regulatory environment** We utilise industry-leading standard operating procedures to ensure compliance with internationally recognised practice guidelines and regulations. **Excellence in execution** We strive for quality in everything we do. We have a proven ability to manage effectively and efficiently the delivery of all types of medical communication programmes. Email us: info@excerptamedica.com

Symbio Proinnovera

The newly announced merger of NY-headquartered Symbio LLC and CA-headquartered Dow Development Laboratories LLC with Munster (Germany)-based Proinnovera will form Symbio Proinnovera, creating one of the world’s largest specialized dermatology-focused clinical research organizations. Founded over 20 years ago, the Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client's dermatology and aesthetics services - from pre-clinical formulation work to subsequent clinical trial execution. Proinnovera was founded 25 years ago and is a leading European CRO in the dermatology clinical trial space. It is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Their combined strength will enable them to excel at addressing customers’ needs and expectations in all areas of research. The newly formed organization will leverage the combined power of two highly experienced teams with deep expertise in the dermatology space to generate efficiencies and accelerate clinical research. Symbio Proinnovera will be supported in its growth by ARCHIMED, a leading investment firm focused exclusively on healthcare industries.

mastelli bio-pharmaceutical company italy

Mastelli is a historical Italian bio-pharmaceutical company with 70 years of experience in the development, production, and marketing of polynucleotides (PN) and polydeoxyribonucleotides (PDRN) for medical applications. Mastelli is the originator company of DNA fractions usage in the world. Mastelli develops and produces internally the global range of PN and PDRN-based drugs and medical devices from raw materials to the sale and distribution of finished products. Mastelli is the only company in the world that has developed over the years a wide range of proposals that integrate DNA fractions with other technologies and are therefore able to offer innovative solutions and protocols for medical applications in several therapeutic areas (aesthetic medicine, orthopedics, gynecology, dermatology, and advanced wound care).

orig pharmaceuticals private limited

ORIG PHARMACEUTICALS PRIVATE LIMITED is a pharmaceutical company based out of NO.18 JARAGNAHALLI, J.P. NAGAR 6TH PHASE, Bangalore, Karnataka, India.

Healol Pharmaceuticals

Healol is a marketing and distribution company with a strong focus on Pharmaceuticals, Genetics, Health Supplements and FMCG. With a strong presence in the ASEAN region, Healol has created brand leaders in all segments of its operations and continues to expand. Traditionally a purely pharmaceutical company focused on quality branded generic drugs, Healol has branched out into Genetics, High Level Disinfectants, High-Tech Medical Equipment and continues to find growth in new sectors like FMCG and Health Supplements.